Product Information
ZOMIG 5 MG NASAL SPRAY is a brand product labeled by Amneal Pharmaceuticals LLC, priced at $108.8863 per EA under NDC 64896008412. Its NADAC has been published 104 times since Oct 9, 2024.
FDA first approved this application on Sep 30, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Zolmitriptan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
64896008412
Classification
Brand
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
ZOLMITRIPTANApproval Type
New Drug (NDA)
FDA Application
NDA021450FDA Approved
9/30/2003
TE Code
AB
On Market Since
7/15/2024
Pharmacological Classes
Price Statistics
The NADAC for ZOMIG 5 MG NASAL SPRAY has been published 104 times since Oct 9, 2024, and over the history we have for it it has risen 15.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $108.8863 per EA |
|---|---|
| All-time high | $109.5042 (Jun 10, 2026) |
| All-time low | $94.0563 (Oct 9, 2024) |
| 52-week high | $109.5042 |
| 52-week low | $101.4868 |
| Median price | $101.4868 |
| Average price | $103.1789 |
| Largest weekly change | +7.9% (Jan 14, 2026) |
| Weeks tracked | 104 |
| Tracking since | Oct 9, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 60% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Zolmitriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZOMIG 5 MG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for ZOMIG 5 MG NASAL SPRAY, manufactured by Amneal Pharmaceuticals LLC, is $108.8863 per EA (NDC 64896008412), effective Sep 30, 2026.
How has the price of ZOMIG 5 MG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for ZOMIG 5 MG NASAL SPRAY has risen 15.8%. It has been tracked across 104 weekly CMS publications since Oct 9, 2024.
What are the highest and lowest recorded NADAC prices for ZOMIG 5 MG NASAL SPRAY?
Since Oct 9, 2024, the NADAC for ZOMIG 5 MG NASAL SPRAY has ranged from a low of $94.0563 (Oct 9, 2024) to a high of $109.5042 (Jun 10, 2026), with a median of $101.4868 per EA.
Are there cheaper alternatives to ZOMIG 5 MG NASAL SPRAY?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZOLMITRIPTAN 5 MG NASAL SPRAY, is $44.0393 per EA — about 60% below ZOMIG 5 MG NASAL SPRAY.
Who manufactures ZOMIG 5 MG NASAL SPRAY?
ZOMIG 5 MG NASAL SPRAY (NDC 64896008412) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a brand product.